Vivos (RDGL) Net Cash Flow (QoQ) (2010 - 2025)
Vivos (RDGL) Net Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.87% |
| Sep 30, 2025 | 24.16% |
| Jun 30, 2025 | -157.43% |
| Mar 31, 2025 | 5.85% |
| Dec 31, 2024 | 296.42% |
| Sep 30, 2024 | -243.18% |
| Jun 30, 2024 | 259.66% |
| Mar 31, 2024 | -499.43% |
| Dec 31, 2023 | 126.16% |
| Sep 30, 2023 | 32.58% |
| Jun 30, 2023 | -7.05% |
| Mar 31, 2023 | -4.25% |
| Dec 31, 2022 | 0.46% |
| Sep 30, 2022 | -65.37% |
| Jun 30, 2022 | 55.47% |
| Mar 31, 2022 | -1.01% |
| Dec 31, 2021 | -113.65% |
| Sep 30, 2021 | 48.71% |
| Jun 30, 2021 | -121.59% |
| Mar 31, 2021 | 80.94% |